Fundamental Analysis
89 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +94.7% | +66.6% | 3 / 3 | +19.5% | +8.21 pp | +2.26 pp | +16.7% | 0.33 | 5.41 | 50,8 | +19,5% | 3,0 | +94,7% | 5.41 | 7.94 | −31,9% |
| Pts | 12 | 12 | 12 | 8 | 12 | 12 | 4 | 12 | 12 | |||||||
Valuation annotation:Price: 13.100 (close price on 2026-10-15)EPS (TTM): 2.422
Financial charts
1.Revenue & growth
VND bn50,8Q2/26
1.Revenue & growth
VND bn50,8Q2/26
2.Profit & growth
VND bn2,97Q2/26
3.Profit mix (Penman)
VND bn12,0Q2/26
4.Margins & cost structure
%44.8%Q2/26
5.Returns & cash cycle
% · days15.7%Q2/26
6.Earnings quality & cash
VND bn6,68Q2/26
7.Asset structure
VND bn121Q2/26
8.Funding & debt health
VND bn · times121Q2/26
9.Revenue backlog
VND bn0,04Q2/26
10.Valuation
times · %6,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %695Q2/26
Adjusted EPS growth, latest quarter
94.7%
Average adjusted EPS growth, 3 quarters
66.6%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26